Treating Inflammatory Lung Disease
AssigneesThe United States Government as represented by the Department of Veterans Affairs, University of Miami
InventorsRobert M. Jackson, Andrew V. Schally, Renzhi Cai
Life of this patent
Estimating the term…
Abstract
Described herein are compositions and methods for treating pulmonary fibrosis and cancer. The compositions include growth hormone releasing hormone peptides. The methods include reducing lung inflammation, lung scarring, reducing expression of T cell receptor complex genes as well as inhibiting tumor growth.
Claims6
A method of reducing lung inflammation, the method comprising:
- administering to a subject with pulmonary fibrosis a therapeutically effective amount of a growth hormone releasing hormone (GHRH) receptor antagonist.
A method of reducing lung scarring, the method comprising:
- administering to a subject with pulmonary fibrosis a therapeutically effective amount of a growth hormone releasing hormone (GHRH) receptor antagonist.
A method of ameliorating one or more symptoms of pulmonary fibrosis, the method comprising:
- administering to a subject with pulmonary fibrosis a therapeutically effective amount of a growth hormone releasing hormone (GHRH) receptor antagonist.
Dependencies are inferred from the claim text.